We are particularly looking forward to the following presentations:

Oct 15, 2024
14.40 JJP-1212 Precision Medicine Approach
Louis Boon, JJP Biologics
15.20 Expanding the scope of conjugatable drugs for ADCs carrying payloads with novel modes of action
Marc-André Kasper, Tubulis GmbH
15.40 Effective Strategies for Successful Bispecific Antibody Development and Manufacturing
Sherry Gu, WuXi Biologics
16.50 Innovative Approaches in Cell Line Development: Leveraging Technology and Case Studies for Scalable Process Optimization
Alejandro Infante, Lonza
17.10 Protein Engineering
Ruediger Jankowsky, AATec Medical GmbH
17.30 Driving Cell Therapy Success: Acro’s GMP Solutions for Seamless Manufacturing
Anil Kumar, ACRObiosystems
17.30 Enhanced vector technology for improved expression control of bispecific antibodies
Peter O’Callaghan, Lonza Biologics
17.30 Small Molecule Therapeutics targeting Fibroblast Activation Protein in the tumor microenvironment
Andrea Galbiati, Philochem

Oct 16, 2024
10.30 Keynote Panel Discussion, sponsored by Genedata: Beyond the Hype: Next Steps for AI in Biologics R&D
Jana Hersch, Genedata + Uwe Wittenberg, Merck Healthcare KGaA + Luciano Lucas, Leica Microsystems
14.20 From DNA-encoded Chemical Libraries to radioligand diagnostics and therapeutics against cancer
Sebastian Oehler, Philochem
16.50 Early clinical results of an anti-CD89 antagonist for treating IgA-mediated autoimmune and fibrotic diseases
Louis Boon, JJP Biologics
17.10 First-in-class inhibitors of ERAP1 generate novel cancer antigens as targets for MHC-I-directed therapies
Wayne Paes, Grey Wolf Therapeutics

Oct 17, 2024
9.00 Formulation, Fill/Finish & Supply Chain
Senior Representative, Lonza

For meeting requests, please send us a private message or contact Wiebke Hallensleben-Steen or Bastian Fleitz via the event app.